Saying “yes” to obese living liver donors: Short-term intensive treatment for donors with hepatic steatosis in living-donor liver transplantation.Nakamuta M, Morizono S, Soejiima Y, Yoshizumi T, Aishima S, Takasugi S, et al. Transplantation 2005;80:608–612.

2006 ◽  
Vol 12 (6) ◽  
pp. 1012-1016 ◽  
Author(s):  
James D. Perkins
Keyword(s):  
Hepatic Steatosis ◽  
Living Donor ◽  
Intensive Treatment ◽  
Donor Liver ◽  
Short Term ◽  
Living Liver Donors ◽  
Liver Donors

Short-Term Intensive Treatment for Donors with Hepatic Steatosis in Living-Donor Liver Transplantation

2005 ◽  
Vol 80 (5) ◽  
pp. 608-612 ◽  
Author(s):  
Makoto Nakamuta ◽  
Shusuke Morizono ◽  
Yuji Soejima ◽  
Tomoharau Yoshizumi ◽  
Shinji Aishima ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Hepatic Steatosis ◽  
Living Donor ◽  
Living Donor Liver Transplantation ◽  
Intensive Treatment ◽  
Donor Liver ◽  
Short Term ◽  
Donor Liver Transplantation

scholarly journals Donor Liver Attenuation Index and Liver Biopsy Correlation in Living Donor Liver Transplantation

2021 ◽  
Vol 15 (7) ◽  
pp. 1772-1775
Author(s):  
Amer Latif ◽  
Sumbul Naz ◽  
Faisal Naseer ◽  
Humaira Alam ◽  
M. Afzal Bhatti ◽  
...  
Keyword(s):  
Body Mass Index ◽  
Liver Transplantation ◽  
Liver Biopsy ◽  
Hepatic Steatosis ◽  
Body Mass ◽  
Donor Liver ◽  
Donor Liver Transplantation ◽  
Attenuation Index ◽  
Living Liver Donors ◽  
Liver Donors

Objective: Using non-invasive methods, such as BMI and CT LAIto suggest a prediction model for hepatic steatosis, examine the CT liver attenuation index and body mass index (BMI)association for pathological steatosis in living liver donors. Histological analysis remains the standard reference. Study Design: Retrospective study Place and Duration of Study: Liver Transplantation Department, Bahria International Hospital Orchard, Lahore from 1st June 2017 to 31st December 2018. Methodology: Fifty-nine donors were included with a median age of 23.00 years, as well as the potential donors for LDLT who experienced evaluation as a potential liver donor. Donors who underwent CT scan and histological liver evaluation were part of this study. Results: Of the donors, forty-eight (81.35%) had a CT LAI ≥1. The median BMI was 22.1 (range: 17.00–33.4). Twenty eight (47.5%) of the patients had undergone liver biopsy for screening in the pre-transplant period whereas 31 (52.5%) of the total evaluated donors underwent biopsy during the transplant. Thirty four (57.62%) out of 59 evaluated living liver donors underwent hepatectomy. Non-significant association (P=0.719) between different categories of BMI as the steatosis increases histologically, whereas significant association (P<.05) for CT LAI as the steatosis increases histologically. Conclusion: Body mass index alone is not a reliable factor for liver fat estimation non-enhanced CT liver-spleen attenuation index of ≤0 correspond to severe hepatic steatosis reserving histopathological liver evaluation via biopsy for selected cases and decreasing the need of liver biopsy while making sure both donor and recipient are safe. Keywords:Living donor liver transplantation, CT LAI, BMI, Liver biopsy

Living Liver Donors: A Coordinator's Perspective

2003 ◽  
Vol 13 (2) ◽  
pp. 82-89 ◽  
Author(s):  
Marian O'Rourke ◽  
Lindsay Arnott ◽  
Jody Scopa Goldman
Keyword(s):  
Liver Transplantation ◽  
Living Donor ◽  
Living Donor Liver Transplantation ◽  
Adverse Outcomes ◽  
Social Psychological ◽  
Donor Liver ◽  
Donor Liver Transplantation ◽  
True Incidence ◽  
Living Liver Donors ◽  
Liver Donors

Living donor liver transplantation is an acceptable alternative for many patients awaiting a liver transplant. The benefits of living donor liver transplantation to the recipient are many; however, there is also an appreciable risk to the donor. Many people, including healthcare professionals, believe that living donor liver transplantation is not ethically justified because any risk to a donor outweighs the benefit to the recipient. Recent studies show adverse events in this population do not include only medical complications; any complication—medical, social, psychological, financial, or other—must be examined to analyze the true incidence of adverse outcomes in living liver donors.

scholarly journals Predicting Hepatic Steatosis in Living Liver Donors Via Controlled Attenuation Parameter

2018 ◽  
Vol 50 (10) ◽  
pp. 3533-3538 ◽  
Author(s):  
Y.H. Yen ◽  
F.Y. Kuo ◽  
C.C. Lin ◽  
C.L. Chen ◽  
K.C. Chang ◽  
...  
Keyword(s):  
Hepatic Steatosis ◽  
Controlled Attenuation Parameter ◽  
Attenuation Parameter ◽  
Living Liver Donors ◽  
Liver Donors

scholarly journals Quantitative survival model for short-term survival after adult-to-adult living donor liver transplantation

2006 ◽  
Vol 12 (6) ◽  
pp. 904-911 ◽  
Author(s):  
Ichiro Tsunematsu ◽  
Yasuhiro Ogura ◽  
Kayoko Inoue ◽  
Akio Koizumi ◽  
Nobuhiko Tanigawa ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Living Donor ◽  
Living Donor Liver Transplantation ◽  
Survival Model ◽  
Donor Liver ◽  
Short Term ◽  
Term Survival ◽  
Donor Liver Transplantation ◽  
Short Term Survival
Sign in / Sign up

Export Citation Format

Share Document